Celldex Therapeutics Hits Day High with Strong 7.91% Intraday Surge

Celldex Therapeutics, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable increase in its stock price today, rising by 7.91%. The stock reached an intraday high of USD 25.11, reflecting a significant uptick in activity. In terms of performance metrics, Celldex's one-day performance outpaced the S&P 500, which recorded a modest gain of 0.69%. Over the past week, Celldex has shown an 8.0% increase, while the S&P 500 managed a 1.07% rise. However, the company has faced challenges over longer periods, with a one-month decline of 4.17% compared to the S&P's 1.66% gain. Despite the recent uptick, Celldex's year-to-date performance remains negative at -8.54%, contrasting with the S&P 500's positive return of 0.94%. The company has reported negative results in its last two quarters, with net sales and operating profit reflecting significant declines. As Celldex navigates its current market position, the stock's performance continues to be closely monitored.